News

Researchers have discovered that a bacterium isolated from the intestines of Japanese tree frogs possesses potent anticancer activity.

Delta-9-tetrahydrocannabinol) and CBD (cannabidiol) from cannabis show promising anti-cancer effects on ovarian cancer cells. Both reduce cell growth, and together they may kill existing cells, pointing to potential new treatments.

Researchers have uncovered differences in how multiple myeloma develops and progresses in men and in women, which could lead to earlier detection and sex-specific treatments.

UK researchers have developed an infrared-based blood test that can detect a single circulating lung cancer cell. Using FT-IR microspectroscopy and computational analysis, the method identifies cancer-specific chemical fingerprints in blood samples.

Researchers have developed a new way to stimulate the immune system to attack cancer cells, in a strategy that could work for many cancers.

Mount Sinai researchers developed a first-in-class cell-selective modRNA translation system that turns therapeutic genes on only in target cells.

Researchers have shown that in mice, cancer disrupts the diurnal rhythms of the primary stress hormone, altering the immune response to the tumor.

A blood test may help identify colon cancer patients who benefit from adding celecoxib to chemotherapy after surgery.

Roswell Park scientists show that IL-36γ–armored CAR T cells reprogram neutrophils to trigger powerful immune responses against solid tumors.

A Dartmouth study reveals how LACTB reshapes the inner membrane trigger apoptosis, opening new paths for cancer and neurodegenerative therapies.